Rifampin Injection Shortage
Last Updated: May 26, 2021
Status: Resolved
Reason for the Shortage
-
- Fresenius Kabi stated the reason for the shortage was a short-term manufacturing delay.
- Mylan had rifampin injection on shortage due to increased demand.
- Sanofi-Aventis had Rifadin IV on shortage due to manufacturing delays.
Available Products
-
- Rifadin IV lyophilized powder for injection, Sanofi-Aventis, 600 mg, vial, 1 count, NDC 00068-0597-01
- Rifampin lyophilized powder for injection, Fresenius Kabi, 600 mg, vial, 1 count, NDC 63323-0351-20
- Rifampin lyophilized powder for injection, Mylan Institutional, 600 mg, vial, 1 count, NDC 67457-0445-60
Estimated Resupply Dates
-
- All marketed presentations are available.
Updated
Updated May 26, 2021 by Michelle Wheeler, PharmD, Drug Information Specialist. Created February 11, 2021 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2021, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.